x
Turning science into breakthroughs
A translational research alliance created to accelerate the development of new therapeutics
In January 2023, Cold Spring Harbor Laboratory (CSHL) and healthcare investment firm Deerfield Management announced a research and development collaboration to help bring next-generation therapeutics to market.
Through a newly launched company called Harbor Discoveries, LLC, Deerfield has committed up to $130 million over a 10-year period and may provide CSHL scientists with both funding and functional expertise to advance biomedical research.
Deerfield is a healthcare investment management firm committed to advancing healthcare through investment, information and philanthropy. For more information, please visit www.deerfield.com.
Founded in 1890, Cold Spring Harbor Laboratory has shaped contemporary biomedical research and education with programs in cancer, neuroscience, plant biology and quantitative biology. Home to eight Nobel Prize winners, the private, not-for-profit Laboratory employs 1,000 people including 600 scientists, students and technicians. For more information, visit www.cshl.edu.
Timeline for Proposal Submissions
Proposal Sourcing
Principal Investigators are invited to submit proposals.
Scientific Review
Your proposal will be reviewed by members of our scientific team.
Full Proposal
If your idea is selected for further evaluation, you will be invited to submit a full proposal.
Investment Evaluated
Your proposal will be carefully evaluated for funding by Deerfield’s investment team.